Of the same family, the enzyme helicase lymphoid-specific (HELLS) was also found to be overexpressed in HCC patients and significantly correlated with poor prognosis due to augmented tumor aggressiveness [74]. Here, HELLS is linked to hepatocellular carcinoma.